|
US4078060A
(en)
*
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
|
US4434228A
(en)
*
|
1982-04-20 |
1984-02-28 |
Genex Corporation |
Immobilization of biological materials in condensed polyalkyleneimine polymers
|
|
US4816568A
(en)
*
|
1986-05-16 |
1989-03-28 |
International Minerals & Chemical Corp. |
Stabilization of growth hormones
|
|
JPS63287730A
(ja)
|
1987-05-20 |
1988-11-24 |
Nippon Shokubai Kagaku Kogyo Co Ltd |
経皮吸収促進剤およびこれを含有してなる皮膚外用剤
|
|
US5420105A
(en)
*
|
1988-09-23 |
1995-05-30 |
Gustavson; Linda M. |
Polymeric carriers for non-covalent drug conjugation
|
|
US5252713A
(en)
*
|
1988-09-23 |
1993-10-12 |
Neorx Corporation |
Polymeric carriers for non-covalent drug conjugation
|
|
US5744166A
(en)
*
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US6126945A
(en)
*
|
1989-10-03 |
2000-10-03 |
Pharmacia Ab |
Tumor killing effects of enterotoxins, superantigens, and related compounds
|
|
US5670617A
(en)
*
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
|
ES2095959T3
(es)
|
1990-10-24 |
1997-03-01 |
Allelix Biopharma |
Inhibidores de la replicacion del virus vih a base de peptidos.
|
|
GB9120306D0
(en)
*
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US5607691A
(en)
*
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
ES2123062T3
(es)
|
1992-08-21 |
1999-01-01 |
Biogen Inc |
Polipeptidos de transporte derivados de la proteina tat.
|
|
US5260082A
(en)
|
1992-09-16 |
1993-11-09 |
Kraft General Foods, Inc. |
Baked goods, doughs or batters, dry mixes and methods for producing thereof
|
|
US5877278A
(en)
*
|
1992-09-24 |
1999-03-02 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
|
DE69428813T2
(de)
|
1993-12-28 |
2002-04-04 |
Allergan Sales Inc |
Verwendung von Botulinustoxin zur Behandlung von Spannungs-Kopfschmerz
|
|
US6986893B2
(en)
*
|
1993-12-28 |
2006-01-17 |
Allergan, Inc. |
Method for treating a mucus secretion
|
|
US6974578B1
(en)
*
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
US5766605A
(en)
*
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
|
EP0758900B1
(en)
*
|
1994-05-09 |
2002-04-10 |
BINDER, William J. |
Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN
|
|
NO180167C
(no)
*
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
|
US6232295B1
(en)
|
1994-10-12 |
2001-05-15 |
Jon Faiz Kayyem |
Cell-specific contrast agent and gene delivery vehicles
|
|
US5512547A
(en)
*
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5756468A
(en)
*
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
GB9508204D0
(en)
*
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
GB9600272D0
(en)
*
|
1996-01-06 |
1996-03-06 |
Univ Nottingham |
Polymers
|
|
AU729643B2
(en)
|
1996-05-01 |
2001-02-08 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
|
FR2755976B1
(fr)
|
1996-11-15 |
1999-01-15 |
Idm Immuno Designed Molecules |
Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
|
|
US6228161B1
(en)
*
|
1996-12-30 |
2001-05-08 |
Minerals Technologies Inc. |
Use of calcium carbonate in an acidic aqueous media
|
|
US5798587A
(en)
*
|
1997-01-22 |
1998-08-25 |
Industrial Technology Research Institute |
Cooling loop structure of high speed spindle
|
|
FR2759298B1
(fr)
|
1997-02-10 |
1999-04-09 |
Rhone Poulenc Rorer Sa |
Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
|
|
CN1263473A
(zh)
*
|
1997-05-21 |
2000-08-16 |
利兰·斯坦福青年大学托管委员会 |
增加跨生物膜转运的组合物和方法
|
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
WO1999024596A1
(en)
|
1997-11-12 |
1999-05-20 |
Valentis, Inc. |
Expression plasmids for multiepitope nucleic acid-based vaccines
|
|
US5985434A
(en)
|
1997-11-25 |
1999-11-16 |
Kimberly-Clark Worldwide, Inc. |
Absorbent foam
|
|
WO1999029721A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
WO1999042091A2
(en)
*
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
|
US6011646A
(en)
|
1998-02-20 |
2000-01-04 |
The Regents Of The Unviersity Of California |
Method to adjust multilayer film stress induced deformation of optics
|
|
ATE365050T1
(de)
*
|
1998-02-25 |
2007-07-15 |
Us Gov Sec Army |
Verwendung von hautpenetrationsförderern und für die zerstörung der oberen hautschichten geeigneten mitteln zur erhöhung der transkutanen immunantwort
|
|
CA2326222C
(en)
|
1998-04-27 |
2008-09-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Medicinal compositions
|
|
US6261679B1
(en)
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
|
EP1117720A4
(en)
*
|
1998-07-13 |
2001-11-14 |
Expression Genetics Inc |
POLYESTER POLY-L-LYSINE ANALOG USED AS A BIODEGRADABLE SOLUBLE GENE CONVEYOR
|
|
US6280937B1
(en)
*
|
1998-08-14 |
2001-08-28 |
Rigel Pharmaceuticals, Inc. |
Shuttle vectors
|
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
WO2000024419A1
(en)
|
1998-10-27 |
2000-05-04 |
Mayo Foundation For Medical Education And Research |
Methods for enhancing wound healing
|
|
AU770963B2
(en)
|
1998-12-02 |
2004-03-11 |
I.D.M. Immuno-Designed Molecules |
New oligomeric conjugates liable to transfer biological molecules into cells
|
|
JP2002531113A
(ja)
|
1998-12-10 |
2002-09-24 |
ワシントン大学 |
蛋白質の形質導入システムおよびその使用法
|
|
US6627632B2
(en)
|
1998-12-14 |
2003-09-30 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
|
DE69825495T2
(de)
|
1998-12-23 |
2005-07-28 |
Idea Ag |
Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
|
|
US7056656B1
(en)
*
|
1999-01-25 |
2006-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
|
|
ES2160485B1
(es)
|
1999-04-23 |
2002-05-16 |
Lipotec Sa |
Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
|
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US7442764B2
(en)
*
|
1999-06-07 |
2008-10-28 |
Mirns Bio Corporation |
Reversible modification of amine-containing compounds
|
|
US20030236214A1
(en)
*
|
1999-06-09 |
2003-12-25 |
Wolff Jon A. |
Charge reversal of polyion complexes and treatment of peripheral occlusive disease
|
|
US7008924B1
(en)
*
|
1999-07-21 |
2006-03-07 |
Amgen, Inc. |
VGF fusion polypeptides
|
|
US6593292B1
(en)
*
|
1999-08-24 |
2003-07-15 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US7229961B2
(en)
*
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6730293B1
(en)
*
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US20030104622A1
(en)
*
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
US6544548B1
(en)
*
|
1999-09-13 |
2003-04-08 |
Keraplast Technologies, Ltd. |
Keratin-based powders and hydrogel for pharmaceutical applications
|
|
US6458763B1
(en)
|
1999-09-17 |
2002-10-01 |
Depuy Orthopeadics |
Bone sialoprotein-based compositions for enhancing connective tissue repair
|
|
US6773928B1
(en)
|
1999-09-22 |
2004-08-10 |
The United States Of America As Represented By The Secretary Of The Army |
Compositions and methods for enhancing bioassay performance
|
|
US6610820B1
(en)
*
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6844324B1
(en)
*
|
1999-11-12 |
2005-01-18 |
Massachusetts Institute Of Technology |
Modular peptide mediated intracellular delivery system and uses therefore
|
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
|
US20040109871A1
(en)
*
|
2000-01-06 |
2004-06-10 |
Pascual David W. |
M cell directed vaccines
|
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US7780967B2
(en)
*
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT411041B
(de)
*
|
2000-05-18 |
2003-09-25 |
Josef Lindenberg |
Verfahren zur herstellung von glasfliesen, glasbordüren, glasdekorpaneelen oder dgl.
|
|
US6670322B2
(en)
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
|
US6306423B1
(en)
*
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US20030215412A1
(en)
|
2000-07-21 |
2003-11-20 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
US20030219462A1
(en)
|
2000-07-21 |
2003-11-27 |
Allergan Sales, Inc |
Clostridial neurotoxin compositions and modified clostridial neurotoxins
|
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US20040220100A1
(en)
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
JP5610659B2
(ja)
|
2000-07-21 |
2014-10-22 |
ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
多成分生物学的輸送システム
|
|
US6696038B1
(en)
*
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US6831059B2
(en)
*
|
2000-10-20 |
2004-12-14 |
Allergan, Inc. |
Compositions and methods for treating gonadotrophin related illnesses
|
|
US20020127247A1
(en)
|
2000-11-17 |
2002-09-12 |
Allergen Sales, Inc. |
Modified clostridial neurotoxins with altered biological persistence
|
|
US20020086036A1
(en)
*
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
|
US7255865B2
(en)
*
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
|
DE60233137D1
(de)
*
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
|
CA2367636C
(en)
*
|
2001-04-12 |
2010-05-04 |
Lisa Mckerracher |
Fusion proteins
|
|
DK1411978T3
(da)
*
|
2001-07-27 |
2009-01-05 |
Univ Louisiana State |
Botulinum-toksin ved behandlingen eller forebyggelsen af acne
|
|
WO2003041128A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Pharmacia Corporation |
Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
|
|
US7060498B1
(en)
*
|
2001-11-28 |
2006-06-13 |
Genta Salus Llc |
Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
|
|
WO2003049772A2
(en)
|
2001-12-11 |
2003-06-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Guanidinium transport reagents and conjugates
|
|
US20030113349A1
(en)
*
|
2001-12-18 |
2003-06-19 |
Coleman William P. |
Topically applied clostridium botulinum toxin compositions and treatment methods
|
|
WO2003059192A2
(en)
*
|
2001-12-21 |
2003-07-24 |
The Trustees Of Columbia University In The City Of New York |
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
|
|
US20030147958A1
(en)
*
|
2002-01-29 |
2003-08-07 |
Cheol-Hee Ahn |
Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
|
|
AU2003211103A1
(en)
*
|
2002-02-13 |
2003-09-04 |
Northeastern University |
Intracellular delivery of therapeutic agents
|
|
AU2003216389A1
(en)
*
|
2002-02-21 |
2003-09-09 |
Essentia Biosystems, Inc. |
Induction of hair growth with vascular endothelial growth factor
|
|
US7476390B2
(en)
*
|
2002-02-26 |
2009-01-13 |
Maxygen, Inc. |
Flavivirus antigens
|
|
DE60335608D1
(de)
|
2002-02-27 |
2011-02-17 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
US6688311B2
(en)
*
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
US7459164B2
(en)
*
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
|
EP1531859A4
(en)
*
|
2002-05-31 |
2005-12-07 |
Univ Jefferson |
COMPOSITIONS AND METHODS FOR TRANSEPITHELIAL MOLECULAR TRANSPORT
|
|
US20040009180A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US20040242518A1
(en)
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US7071167B2
(en)
*
|
2002-11-13 |
2006-07-04 |
L'oreal |
Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
|
|
US6866856B2
(en)
*
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
WO2004084805A2
(en)
*
|
2003-03-19 |
2004-10-07 |
The J. David Gladstone Institutes |
Acetylated tat polypeptides and methods of use thereof
|
|
WO2004084839A2
(en)
|
2003-03-24 |
2004-10-07 |
Cady Roger K |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
US20040192754A1
(en)
|
2003-03-24 |
2004-09-30 |
Shapira Nathan Andrew |
Methods for treating idiopathic hyperhidrosis and associated conditions
|
|
WO2005030119A2
(en)
*
|
2003-04-11 |
2005-04-07 |
Allergan, Inc. |
Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
|
US7883720B2
(en)
*
|
2003-07-09 |
2011-02-08 |
Wisconsin Alumni Research Foundation |
Charge-dynamic polymers and delivery of anionic compounds
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
US8871224B2
(en)
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
|
JP2007527431A
(ja)
*
|
2004-03-03 |
2007-09-27 |
ルバンス セラピュティックス |
局所的診断及び治療用の輸送のための組成物及び方法
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
BRPI0508410B8
(pt)
|
2004-03-03 |
2021-05-25 |
Revance Therapeutics Inc |
composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
|
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20060040882A1
(en)
*
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
GB2416122A
(en)
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
EP2266599B1
(en)
*
|
2004-07-26 |
2014-04-16 |
Merz Pharma GmbH & Co. KGaA |
Therapeutic composition with a botulinum neurotoxin
|
|
US20060024331A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
|
JP2006067889A
(ja)
*
|
2004-09-01 |
2006-03-16 |
Japan Science & Technology Agency |
Ｐｅｏと二本鎖核酸のコンジュゲート
|
|
EP1661912A1
(en)
|
2004-11-29 |
2006-05-31 |
Xigen S.A. |
Fusion protein comprising a BH3-domain of a BH3-only protein
|
|
MX2007010674A
(es)
|
2005-03-03 |
2007-11-08 |
Revance Therapeutics Inc |
Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
|
|
ZA200707352B
(en)
|
2005-03-03 |
2009-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US20100116664A1
(en)
*
|
2005-03-08 |
2010-05-13 |
Ignatius Michael J |
Monitoring and manipulating cellular transmembrane potentials using nanostructures
|
|
ES2353814T3
(es)
*
|
2005-05-11 |
2011-03-07 |
Eth Zuerich |
Proteinas n-glicosiladas recombinantes de celulas procariotas.
|
|
US8168206B1
(en)
*
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
US8137677B2
(en)
*
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
|
CN103126971A
(zh)
|
2005-11-17 |
2013-06-05 |
雷文斯治疗公司 |
减少非毒素蛋白质的肉毒杆菌毒素组合物和其局部施用及透皮递送方法
|
|
US20100021502A1
(en)
*
|
2006-12-28 |
2010-01-28 |
Waugh Jacob M |
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
|
|
CN102988995A
(zh)
|
2006-12-29 |
2013-03-27 |
雷文斯治疗公司 |
用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
|
|
BRPI0720729A2
(pt)
|
2006-12-29 |
2014-04-08 |
Revance Therapeutics Inc |
Moléculas de transporte que utilizam polipeptídeos hiv-tat de sequência inversa.
|
|
CN101983070B
(zh)
*
|
2008-02-20 |
2016-03-30 |
格林考瓦因有限公司 |
由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物
|
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
|
US20120014894A1
(en)
*
|
2008-12-31 |
2012-01-19 |
Revance Therapeutics, Inc. |
Compositions and Methods for Treating Hyperpigmentation
|
|
HUE037595T2
(hu)
|
2008-12-31 |
2018-09-28 |
Revance Therapeutics Inc |
Injektálható botulinum toxin készítmények
|
|
EP2413947B1
(en)
*
|
2009-04-01 |
2020-04-29 |
Revance Therapeutics, Inc. |
Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
|
|
IL268980B
(en)
*
|
2009-06-25 |
2022-09-01 |
Revance Therapeutics Inc |
Albumin-free botulinum toxin formulations
|
|
US8697090B2
(en)
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
CA2848740A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Mingxing Wang |
Amphiphilic cationic polymers for the delivery of therapeutic agents
|
|
CA3018046A1
(en)
*
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9541558B2
(en)
*
|
2012-09-05 |
2017-01-10 |
California Institute Of Technology |
Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses
|
|
MX370929B
(es)
*
|
2012-10-28 |
2020-01-08 |
Revance Therapeutics Inc |
Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
|